dc.rights.license | CC-BY-NC-ND | |
dc.contributor.advisor | Externe beoordelaar - External assesor, | |
dc.contributor.author | Schürmann, Paul | |
dc.date.accessioned | 2025-09-03T23:02:25Z | |
dc.date.available | 2025-09-03T23:02:25Z | |
dc.date.issued | 2025 | |
dc.identifier.uri | https://studenttheses.uu.nl/handle/20.500.12932/50314 | |
dc.description.sponsorship | Utrecht University | |
dc.language.iso | EN | |
dc.subject | We used the recently developed CRISPR-Cas9 base-editing to introduce hotspot mutations in endometrial organoids and establish a model of early tumorigenesis. We sequentially introduced PTEN, PIK3CA and TP53 mutations, three of the most frequently mutated genes in endometrial cancer and established a drug screening platform to investigate the sensitivity of these models to different modulators of the PI3K pathway. | |
dc.title | Using adult stem cells-derived organoids to model endometrial homeostasis and disease | |
dc.type.content | Master Thesis | |
dc.rights.accessrights | Open Access | |
dc.subject.courseuu | Drug Innovation | |
dc.thesis.id | 53590 | |